Literature DB >> 11691788

Quantitative T1rho magnetic resonance imaging of RIF-1 tumors in vivo: detection of early response to cyclophosphamide therapy.

U Duvvuri1, H Poptani, M Feldman, L Nadal-Desbarats, M S Gee, W M Lee, R Reddy, J S Leigh, J D Glickson.   

Abstract

This study compares two potential magnetic resonance imaging (MRI) indices for noninvasive early detection of tumor response to chemotherapy: the spin-lattice relaxation in the rotating frame (T1rho) and the transverse relaxation time (T2). Measurements of these relaxation parameters were performed on a s.c. murine radiation-induced fibrosarcoma (RIF-1) model before and after cyclophosphamide treatment. The number of pixels exhibiting T1rho values longer than controls in viable regions of the tumor increased significantly as early as 18 h after drug administration and remained elevated up to 36 h after treatment (P < 0.005). Although a trend of increasing T2s relative to controls was noted in viable regions of the tumor 36 h after treatment, the changes were not statistically significant. Histological examination indicated a decrease in mitotic index that paralleled the changes in T1rho. We conclude that T1rho measurements may be useful for noninvasive monitoring of early response of tumors to chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11691788

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Assessing Myocardial Disease Using T MRI.

Authors:  Yuchi Han; Timo Liimatainen; Robert C Gorman; Walter R T Witschey
Journal:  Curr Cardiovasc Imaging Rep       Date:  2014-02-01

2.  Effects of the tumor vasculature targeting agent NGR-TNF on the tumor microenvironment in murine lymphomas.

Authors:  H W M van Laarhoven; G Gambarota; A Heerschap; J Lok; I Verhagen; A Corti; S Toma; C Gallo Stampino; A van der Kogel; C J A Punt
Journal:  Invest New Drugs       Date:  2006-01       Impact factor: 3.850

3.  Glioma cell density in a rat gene therapy model gauged by water relaxation rate along a fictitious magnetic field.

Authors:  Timo Liimatainen; Alejandra Sierra; Timothy Hanson; Dennis J Sorce; Seppo Ylä-Herttuala; Michael Garwood; Shalom Michaeli; Olli Gröhn
Journal:  Magn Reson Med       Date:  2011-06-30       Impact factor: 4.668

Review 4.  New insights into rotating frame relaxation at high field.

Authors:  John T Spear; John C Gore
Journal:  NMR Biomed       Date:  2016-02-11       Impact factor: 4.044

5.  Measurements of T1 and T2 relaxation times of colon cancer metastases in rat liver at 7 T.

Authors:  G Gambarota; A Veltien; H van Laarhoven; M Philippens; A Jonker; O R Mook; W M Frederiks; A Heerschap
Journal:  MAGMA       Date:  2004-12-01       Impact factor: 2.310

6.  Application of 23Na MRI to monitor chemotherapeutic response in RIF-1 tumors.

Authors:  Andriy M Babsky; Shahryar K Hekmatyar; Hong Zhang; James L Solomon; Navin Bansal
Journal:  Neoplasia       Date:  2005-07       Impact factor: 5.715

7.  R1ρ sensitivity to pH and other compounds at clinically accessible spin-lock fields in the presence of proteins.

Authors:  Nana Owusu; Casey P Johnson; William Kearney; Dan Thedens; John Wemmie; Vincent A Magnotta
Journal:  NMR Biomed       Date:  2019-11-19       Impact factor: 4.044

8.  Water spin dynamics during apoptotic cell death in glioma gene therapy probed by T1rho and T2rho.

Authors:  A Sierra; S Michaeli; J-P Niskanen; P K Valonen; H I Gröhn; S Ylä-Herttuala; M Garwood; O H Gröhn
Journal:  Magn Reson Med       Date:  2008-06       Impact factor: 4.668

9.  Whole brain mapping of water pools and molecular dynamics with rotating frame MR relaxation using gradient modulated low-power adiabatic pulses.

Authors:  Ovidiu C Andronesi; Himanshu Bhat; Martin Reuter; Shreya Mukherjee; Peter Caravan; Bruce R Rosen
Journal:  Neuroimage       Date:  2013-12-15       Impact factor: 6.556

10.  Spin-lock imaging of intrinsic susceptibility gradients in tumors.

Authors:  Zhongliang Zu; Vaibhav Janve; John C Gore
Journal:  Magn Reson Med       Date:  2019-12-27       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.